~~<i id='93E267B7D3'><strike id='93E267B7D3'><tt id='93E267B7D3'><pre id='93E267B7D3'></pre></tt></strike></i>~~

Home» Wikipedia» entertainment

entertainment

author：explore 2025-09-28 00:16:23 Page View：2

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The nurse manager staffing crisis is hurting patients
Next article： Anesthesiologist group: stop taking Ozempic before surgery

knowledge

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

Caregivers of transplant patients call for more support, training

IraCoppermanwithhiswife,GlendaDaggert.JessicaRinaldi/GlobeStaffBythetimehiswifeGlendaDaggertreceived

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

FILE-PrinceHarryleavestheHighCourtaftergivingevidenceinLondon,Wednesday,June7,2023.PrinceHarryisseek